![Tomer Berkovitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomer Berkovitz
Director/Board Member at
SOPHIA GENETICS SA
Profile
Tomer Berkovitz is currently an Independent Non-Executive Director at SOPHiA GENETICS SA since 2021, a Director at PrognomIQ, Inc. since 2020, and Managing Partner at aMoon Ventures Y Sh Ltd. since 2023.
Former positions include Director at Zebra Medical Vision Ltd. from 2018 to 2021, Chief Operating & Financial Officer at Alcobra Ltd. from 2014 to 2018, Executive Director in the Investment Banking Division at JPMorgan Chase Bank, NA (New York), Director at Mapi-Pharma Ltd., and General Partner at aMoon Fund.
Education includes undergraduate and graduate degrees from Tel-Aviv University and a doctorate from Columbia Business School.
Tomer Berkovitz active positions
| Companies | Position | Start |
|---|---|---|
| SOPHIA GENETICS SA | Director/Board Member | 2021-02-28 |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Private Equity Investor | 2018-01-31 |
PrognomIQ, Inc.
 PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Director/Board Member | 2020-09-14 |
Former positions of Tomer Berkovitz
| Companies | Position | End |
|---|---|---|
Zebra Medical Vision Ltd.
 Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Provides a medical imaging research platform services | Director/Board Member | 2021-11-29 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Director of Finance/CFO | 2017-12-31 |
aMoon Fund
 aMoon Fund Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
| MAPI PHARMA LTD | Director/Board Member | - |
JPMorgan Chase Bank, NA (New York)
 JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Corporate Officer/Principal | - |
Training of Tomer Berkovitz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JPMorgan Chase Bank, NA (New York)
JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Finance |
Mapi-Pharma Ltd.
 Mapi-Pharma Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of generic drugs that include complex active pharmaceutical ingredients, formulations and life cycle management products | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SOPHiA GENETICS SA
 SOPHiA GENETICS SA Packaged SoftwareTechnology Services Develops software services for healthcare industry | Technology Services |
Zebra Medical Vision Ltd.
Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Provides a medical imaging research platform services | Technology Services |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focus on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
aMoon Fund
aMoon Fund Investment ManagersFinance Acts as Venture Capital Fund | Finance |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology Develops and commercializes multi-omics human tests for cancer and other diseases | Health Technology |
- Stock Market
- Insiders
- Tomer Berkovitz
